Skip to main content
Log in

Osteogenesis imperfecta: Effect of magnesium administration on pyrophosphate metabolism

  • Original Papers
  • Published:
Calcified Tissue Research Aims and scope Submit manuscript

Abstract

The bone collagen of human osteogenesis imperfecta is a potent inhibitor ofin vitro calcification. The inhibition was removed by treatment of the collagen with pyrophosphate in the presence of magnesium ions. Elevated levels of serum and urinary inorganic pyrophosphate were found in 28 patients with osteogenesis imperfecta. Oral administration of magnesium oxide or magnesium sulfate to four of these patients significantly reduced their serum and urinary levels of pyrophosphate.

Résumé

Du collagène osseux provenant de fragments d'ostéogenèse imparfaite est un puissant inhibiteur de la calcificationin vitro. Cet effet inhibiteur peut être supprimé par traitement du collagène à la pyrophosphatase en présence d'ions de magnésium. Des concentrations élevées de pyrophosphates inorganiques sérique et urinaire ont été observées chez 28 malades atteints d'ostéogenèse imparfaite. L'administration buccale d'oxyde de magnésium ou de sulfate de magnésium à quatre de ces malades diminue de façon significative la quantité des pyrophosphates sérique et urinaire.

Zusammenfassung

Der Knochenkollagen von Osteogenesis imperfecta-Kranken ist ein mächtiger Hemmstoff für die Verkalkung in vitro. Die Inhibition wird durch Behandlung des Kollagens mit Pyrophosphatase in Anwesenheit von Magnesiumionen aufgehoben. Erhöhte Spiegel von anorganischem Pyrophosphat wurden im Urin und im Serum von 28 Kranken mit Osteogenesis imperfecta gefunden. Wurden 4 Patienten mit peroralen Gaben von Magnesiumoxyd oder Magnesiumsulfat behandelt, so verminderte sich der Pyrophosphatspiegel im Serum und im Urin signifikant.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Avioli, L. V., J. E. McDonald, andR. A. Singer: Excretion of pyrophosphate in disorders of bone metabolism. J. clin. Endocr.25, 912–915 (1965).

    PubMed  Google Scholar 

  • Bongiovani, A. M., M. M. Album, A. W. Root, andJ. W. Hope: Metabolic studies in hypophosphatasia and response to high phosphate intake. Abstr. Soc. Ped. Res. Pg. 6 (April 1967).

    Google Scholar 

  • Chen, P. S., T. Y. Toribara, andH. Warner: Microdetermination of phosphorus. Analyt. Chem.28, 1756–1758 (1956).

    Google Scholar 

  • Clark, I.: Effects of magnesium ions on calcium and phosphorus metabolism. Amer. J. Physiol.214, 348–356 (1968).

    PubMed  Google Scholar 

  • Fleisch, H., andS. Bisaz: Mechanisms of calcification: Inhibitory role of pyrophosphate. Nature (Lond.)195, 911 (1962a).

    Google Scholar 

  • ——: Isolation from urine of pyrophosphate, a calcification inhibitor. Amer. J. Physiol.203, 671–675 (1962b).

    PubMed  Google Scholar 

  • —, andW. F. Neuman: Mechanisms of calcification: Role of collagen, polyphosphates, and phosphatase. Amer. J. Physiol.200, 1296–1300 (1961).

    PubMed  Google Scholar 

  • —, andR. G. G. Russell, andS. Bisaz: Influence of pyrophosphate on the transformation of amorphous to crystalline calcium phosphate. Calc. Tiss. Res.2, 49–59 (1968).

    Google Scholar 

  • Gitelman, H. J., S. Kukolj, andL. G. Welt: Inhibition of parathyroid gland activity by hypermagnesemia. Amer. J. Physiol.215, 483–485 (1968).

    PubMed  Google Scholar 

  • Horn, A., H. Bornig, andG. Thiele: Allosteric properties of the magnesium-dependent inorganic pyrophosphatase in mouse liver cytoplasm. Europ. J. Biochem.2, 243–249 (1967).

    PubMed  Google Scholar 

  • Irving, J. T., D. Schibler, andH. Fleisch: Bone formation in normal and Vit. D-treated rachitic rats during the administration of polyphosphates. Proc. Soc. exp. Biol. (N.Y.)122, 852–856 (1966).

    Google Scholar 

  • MacIntyre, I.: The flame spectrophotometric determination of calcium in biological fluids and on isotopic analysis of the errors in the Kramer-Tisdall Procedure. Biochem. J.67, 164–172 (1957).

    PubMed  Google Scholar 

  • Neuman, W. F.: Metabolic interrelations.: Josiah Macy Jr. Foundation, 187 (1950); 205 (1951).

  • —, andM. W. Neuman: The chemical dynamics of bone mineral., p. 31. Chicago: Chicago University Press 1958.

    Google Scholar 

  • Sauberlich, H. E., G. E. Bunce, C. A. Moore, andO. G. Stonington: Oral magnesium in the treatment of renal calculus formation. Amer. J. clin. Nutr.14, 240 (1964).

    Google Scholar 

  • Siegel, B. M., I. A. Friedman, andS. O. Schwartz: Hemorrhagic disease in osteogenesis imperfecta. Amer. J. Med.22, 315–321 (1957).

    PubMed  Google Scholar 

  • Solomons, C. C.: The control of calcification in osteogenesis imperfecta. Society for Pediatric Research Abstr., p. 38 (1967).

  • —, andW. F. Neuman: On the mechanisms of calcification: The remineralization of dentin. J. biol. Chem.235, 2502–2506 (1960).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This investigation was supported by U.S. Public Health Service Grant AM 08757-05 Division of Arthritis and Metabolic Diseases.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Solomons, C.C., Styner, J. Osteogenesis imperfecta: Effect of magnesium administration on pyrophosphate metabolism. Calc. Tis Res. 3, 318–326 (1969). https://doi.org/10.1007/BF02058674

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02058674

Key words

Navigation